Sun's generic of anticoagulant Plavix receives FDA approval

07/31/2011 | Business Standard (India)

The FDA is allowing Sun Pharmaceutical Industries to launch a 75-milligram dose of clopidogrel USP, a generic version of Sanofi and Bristol-Myers Squibb's anticoagulant Plavix. The tablet is given to patients with "acute coronary syndrome, recent myocardial infarction ... recent stroke or established peripheral arterial disease," Sun said.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care